Literature DB >> 11686314

Lipoprotein analysis using agarose gel electrophoresis and differential staining of lipids.

T Kido1, H Kurata, A Matsumoto, R Tobiyama, T Musha, K Hayashi, S Tamai, K Utsunomiya, N Tajima, N Fidge, H Itakura, K Kondo.   

Abstract

We established a strategy to directly measure cholesterol and triglyceride levels of each lipoprotein fraction using a combination of agarose gel electrophoresis and differential staining. The cholesterol and triglyceride levels determined by electrophoresis correlated significantly with those of ultracentrifugation. The correlation coefficients between these methods were, for cholesterol levels 0.975(very low density lipoproteins, VLDL), 0.986(low density lipoproteins, LDL) and 0.965(high density lipoproteins, HDL) and for triglyceride levels 0.994(VLDL), 0.963(LDL) and 0.959(HDL) respectively. Both intra-and inter-assays showed low values of coefficients of variation (CV) (less than 3.57%). We observed a strong linearity between staining and triglyceride concentration. An increased VLDL-cholesterol was observed in type III subjects, a result which enabled distinction between type III and type IIb or type V lipoproteinemia. The method revealed lipoprotein patterns in some samples otherwise unexpected from their corresponding serum lipid parameters. Analyses of these electrophoretic patterns thus provide an effective technique to classify types of hyperlipidemia defined by the WHO. Furthermore, quantitative measurement of chylomicrons, usually difficult, proved to be achievable, providing an additional analysis of postprandial hyperlipidemia and the exact measurement of LDL-cholesterol after diet. Consequently, we recommend this simple and easy method for clinical evaluation of abnormalities in lipoprotein profiles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686314     DOI: 10.5551/jat1994.8.7

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  9 in total

1.  Present status of the standardization of HDL-C, LDL-C, and TG measurement values available in Japan.

Authors:  Yasuhito Nakajima; Hachiro Yamanishi; Nariaki Matsuura
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

Review 2.  Diabetic dyslipidemia: evaluation and mechanism.

Authors:  Hidekatsu Yanai; Yuji Hirowatari; Hiroshi Yoshida
Journal:  Glob Health Med       Date:  2019-10-31

3.  Potential use of cholesterol lipoprotein profile to confirm obesity status in dogs.

Authors:  Nobuko Mori; Peter Lee; Kazuo Kondo; Toshimi Kido; Terumasa Saito; Toshiro Arai
Journal:  Vet Res Commun       Date:  2011-02-15       Impact factor: 2.459

4.  Dietary effect of Pleurotus eryngii on biochemical function and histology in hypercholesterolemic rats.

Authors:  Nuhu Alam; Ki Nam Yoon; Jae Seong Lee; Hae Jin Cho; Mi Ja Shim; Tae Soo Lee
Journal:  Saudi J Biol Sci       Date:  2011-08-03       Impact factor: 4.219

5.  Antihyperlipidemic activities of Pleurotus ferulae on biochemical and histological function in hypercholesterolemic rats.

Authors:  Nuhu Alam; Ki Nam Yoon; Tae Soo Lee
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

6.  Hypolipidemic Activities of Dietary Pleurotus ostreatus in Hypercholesterolemic Rats.

Authors:  Nuhu Alam; Ki Nam Yoon; Tae Soo Lee; U Youn Lee
Journal:  Mycobiology       Date:  2011-03-23       Impact factor: 1.858

7.  Antihyperlipidemic Effect of Dietary Lentinus edodes on Plasma, Feces and Hepatic Tissues in Hypercholesterolemic Rats.

Authors:  Ki Nam Yoon; Nuhu Alam; Jae Seong Lee; Hae Jin Cho; Hye Young Kim; Mi Ja Shim; Min Woong Lee; Tae Soo Lee
Journal:  Mycobiology       Date:  2011-06-16       Impact factor: 1.858

8.  Appraisal of Antihyperlipidemic Activities of Lentinus lepideus in Hypercholesterolemic Rats.

Authors:  Ki Nam Yoon; Jae Seong Lee; Hye Young Kim; Kyung Rim Lee; Pyung Gyun Shin; Jong Chun Cheong; Young Bok Yoo; Nuhu Alam; Tai Moon Ha; Tae Soo Lee
Journal:  Mycobiology       Date:  2011-12-07       Impact factor: 1.858

9.  FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.

Authors:  Yoshinari Uehara; Setsuko Ando; Eiji Yahiro; Kosuke Oniki; Makoto Ayaori; Satomi Abe; Emi Kawachi; Bo Zhang; Seijiro Shioi; Hiroyuki Tanigawa; Satoshi Imaizumi; Shin-Ichiro Miura; Keijiro Saku
Journal:  J Am Heart Assoc       Date:  2013-05-24       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.